by Vandana Singh | Mar 2, 2026 | General
uniQure N.V. (NASDAQ:QURE) announced on Monday that the FDA has advised against using Phase 1/2 study data as primary evidence for the marketing application of AMT-130, its investigational gene therapy for Huntington’s disease. The FDA strongly recommended that...
by Piero Cingari | Mar 2, 2026 | General
Oil is on track to notch its most violent session in four years. West Texas Intermediate futures surged more than 8% to about $72 per barrel Monday morning as markets reacted to coordinated U.S. and Israeli strikes on Iran, including the confirmed killing of Supreme...
by Lekha Gupta | Mar 2, 2026 | General
Venture Global (NYSE:VG) shares are up during Monday’s premarket session fueled by Brent crude’s sharp climb on U.S.-Iran hostilities. Brent crude surged roughly 8% to about $78.70 a barrel on Monday, climbing sharply after unprecedented strikes intensified...
by Parshwa Turakhiya | Mar 2, 2026 | General
On-chain analyst Joao Wedson wrote, “set your bot to buy every dump,” after Bitcoin’s (CRYPTO: BTC) 180-day Sharpe Ratio flashed what he called a historical accumulation signal. The 180-Day Signal Is In—But The 1-Year Is Not Wedson said the 180-day...
by Avi Kapoor | Mar 2, 2026 | General
As of March 2, 2026, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its...
Recent Comments